The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms

Abstract

The aim of the study was to determine the spectrum of clinical ocular involvement in patients with inactive systemic lupus erythematosus (SLE) who have no ocular symptoms. Patients with a diagnosis of SLE based on the 1982 revised American College of Rheumatology criteria and with no ocular complaints were recruited from the SLE clinic. Clinical data regarding their systemic disease and disease activity were recorded and a full ophthalmic examination carried out.

52 patients of mixed ethnicity comprising of 75% Chinese, 19% Malays and 6% Indian patients were recruited. Of these, 51 (98%) were female with a mean age of 34 11 (range 16–74 y). 16 (31%) patients had dry eyes while corticosteroid induced glaucoma and cataract was detected in 1 (2%) and 7 (14%) patients, respectively. No patients were found to have sight-threatening ocular conditions such as cotton wool spots, vasculitis, optic neuropathy or uveitis.

Patients with clinically inactive disease were found not to have sight-threatening ocular diseases that are known to be associated with SLE. Although they have no ocular complaints, nearly one-third of these patients have dry eyes. Ocular examination may be unnecessary when the disease is clinically inactive and in the absence of ocular symptoms.

Keywords

lupus dry eye cataract glaucoma steroid-induced

Get full access to this article

View all access options for this article.

References

Jabs DA , Miller NR , Newman SA et al. Optic neuropathy in systemic lupus erythematosus . Arch Ophthalmol 1986;104: 564–568 .

Jabs DA . Ocular manifestations of the rheumatic diseases. In: Tasman W , Jaeger EA (eds). Duane's Clinical Ophthalmology. JB Lippincott:Philadelphia , 1994, vol 5, chap 26, pp 10–13.

Eckstein MB , Spalton DJ , Holder G . Visual loss from central serous retinopathy in systemic lupus erythematosus . Br J Ophthalmol 1993;77: 607–609 .

Vine AK , Barr CC . Proliferative lupus retinopathy . Arch Ophthalmol 1984;102: 852–854 .

Jabs DA , Hanneken AM , Schachat AP , Fine SL . Choroidopathy in systemic lupus Erythematosus . Arch Ophthalmol 1988;106: 230–234 .

Huey C , Jakobiec FA , Iwamoto T et al. Discoid lupus erythematosus of the eyelids . Ophthalmology 1983;90: 1389–1398 .

Snyers B , Lambert M , Hardy JP . Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies . Retina 1990;10: 255–260 .

Jabs DA , Fine SL , Hochberg MC et al. Severe retinal vaso-occlusive disease in systemic lupus erythematosus . Arch Ophthalmol 1986;104: 558–563 .

Aronson AJ , Ordonez NG , Diddie KR , Ernest JT . Immune complex deposition in the eye in systemic lupus erythematosus . Arch Intern Med 1979;139: 1312–1313 .

10.

Wong K , Ai E , Jones JV , Young D . Visual loss as the initial symptom of systemic lupus erythematosus . Am J Ophthalmol 1981;92: 238–244 .

11.

Frith P , Burge SM , Millard PR , Wojnarowska F . External ocular findings in lupus erythematosus:a clinical and immunopathological study . Br J Ophthalmol 1990;7: 163–167 .

12.

Wang F , Wang CL , Tan CT , Manivasagar M . Systemic lupus erythematosus in Malaysia:a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups . Lupus 1997;6: 248–253 .

13.

Frank AO . Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia . Ann Rheum Dis 1980;39: 266–269 .

14.

Gold DH , Morris DA , Henkind P . Ocular findings in systemic lupus erythematosus . Br J Ophthalmol 1972;56: 800–804 .

15.

Lanham JG , Barrie T , Kohner EM . Systemic lupus erythematosus retinopathy, evalution by fluorescein angiography . Ann Rheum Dis 1982;41: 473–478 .

16.

Yap EY , Au Kong KG , Fong KY et al. Ophthalmic manifestations in Asian patients with systemic lupus erythematosus . Sing Med J 1998;39: 557–559 .

17.

Reddy CV , Foster CS . Systemic lupus erythematosus. In: Albert DM , Jakobiec FA (eds). Principles and Practice of Ophthalmology. WB Saunders:Philadelphia , 1994, pp 2894–2901.

18.

Farris RL. Sjogren's syndrome. In: Gold DH , Weingeist TA (eds). The Eye in Systemic Disease. JB Lippincott:Philadelphia , 1990, pp 70–71.

19.

Karesh JW , Baer JC , Hemady RK. Noninfectious orbital inflammatory disease. In: Tasman W , Jaeger EA (eds). Duane's Clinical Ophthalmology. JB Lippincott:Philadelphia , 1994 vol. 2, chap 35, pp 28–30.

20.

Lemp MA , Marquardt R. The Dry Eye. Springer-Verlag:Berlin , 1992, pp 9–11.

21.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982;25: 1271–1277 .

22.

Stafford-Brady FJ , Urowitz MB , Gladman DD , Easterbrook M . Lupus retinopathy. Patterns, associations and prognosis . Arthitis Rheum 1988;31: 1105–1110 .

23.

Klinkhoff AV , Beattie CW , Chalmers A . Retinopathy in systemic lupus erythematosus:relationship to disease activity . Arthitis Rheum 1986;29: 1152–1156 .

24.

Sullivan JH . Lids and lacrimal apparatus. In: Vaughan D , Asbury T (eds). General Ophthalmology. 13th edn. Prentice-Hall:London , 1992, p 92-92.

25.

Arrigg CA . Corticosteroid induced glaucoma. In: Albert DM , Jakobiec FA (eds). Principles and Practice of Ophthalmology. WB. Saunders:Philadelphia , 1994, vol. 3 pp 1462–1466.